As hospital bills climb, consumers may bear the final cost

2026-03-11 - 23:33

The BPJS has stopped covering trastuzumab for patients treated under its state-funded National Health Insurance-Healthy Indonesia Card (JKN-KIS) scheme since April 1, arguing that the medication’s effectiveness was not empirically proven.